6
Funding Rounds
$4.6m
Money raised
Nanomedicine company developing vaccines and therapies with cell-specific targeting.
6
Funding Rounds
$86.6m
Money raised
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
14
Funding Rounds
$87.2m
Money raised
A medical company in Massachusetts focusing on lowering the cost of vaccine distribution.
Industries:
Location:
Key people:
- Michael Schrader (entrepreneur) *******@vaxess.com
- Fiorenzo Omenetto ********.********@tufts.edu
- Livio Valenti *****@vaxess.com
12
Funding Rounds
$2.8m
Money raised
HelixNano is a Cambridge, Massachusetts-based biotechnology and artificial intelligence company founded in 2013 by Hannu Rajaniemi and Nikolai Eroshenko.
Industries:
Key people:
- Hannu Rajaniemi *****@helixnano.com
- Nikolai Eroshenko *******@helixnano.com
2
Funding Rounds
$11.3m
Money raised
Emergex aims to tackle the global threat of infectious disease by providing affordable and practical on-demand vaccine solutions.
Industries:
Location:
Key people:
- Thomas Rademacher linkedin
- Storme Moore-Thornicroft *.*****************@gyldenpharma.com
5
Funding Rounds
$26.8m
Money raised
A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.
Industries:
Key people:
1
Funding Rounds
$10.5m
Money raised
SmartPharm Therapeutics is a Cambridge, MA-based gene therapy company applying the next generation of non-viral DNA and RNA technologies to treat serious human diseases.
Industries:
1
Funding Rounds
$150.0k
Money raised
CaroGen is an immunotherapy company that develops vaccine candidates that target hepatitis B and C, as well as other viral agents.
Location:
Key people:
- Valerian Nakaar *******@carogencorp.com
- Bijan Almassian **********@carogencorp.com
- Michael Robek
6
Funding Rounds
$227.7m
Money raised
Translate Bio is a clinical-stage mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction and vaccines against infectious disease pathogens.
Industries:
Key people:
- Michael Heartlein linkedin
- Ankit Mahadevia **********@sperotherapeutics.com
- Jean-Francois Formela linkedin
2
Funding Rounds
$37.5m
Money raised
A biomedical company in United Kingdom that develops vaccines and vaccine development technology
3
Funding Rounds
$68.0m
Money raised
A biotechnology company developing immune-modulation therapies for infectious diseases and cancer leveraging its technology platform and understanding of immune system mechanisms. It was founded in 2009 and is located in Vienna, Austria.
Industries:
Key people:
2
Funding Rounds
$10.5m
Money raised
Synthetic biology company developing vaccines and therapeutics using cell-free biology technology
Industries:
Location:
Key people:
5
Funding Rounds
$72.3m
Money raised
A pharmaceutical company focused on advancement of unmet vaccines against viruses that cause serious human diseases such as respiratory syncytial virus (RSV). Meissa Vaccines applies their platform technology for viral genetic engineering to multiple pathogens.
Industries:
Location:
Key people:
- Roderick Tang ********.****@meissavaccines.com
- Marty Moore ******.*****@meissavaccines.com
9
Funding Rounds
$4.3m
Money raised
A computational immunology and vaccine development company based in Providence, Rhode Island. It was founded in 1998.
5
Funding Rounds
$26.0m
Money raised
DCPrime is a biotechnology company developing cancer immunotherapies.
Industries:
Location:
Key people:
2
Funding Rounds
$60.6m
Money raised
A biotechnology company developing nucleic acid immunotherapy platform and protein based vaccines
Industries:
Key people:
3
Funding Rounds
$50.6m
Money raised
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
Industries:
Key people:
- Burak Yilmaz *****@kernalbio.com
- Cafer Ozdemir *****@kernalbio.com
- Yusuf Erkul *****@kernalbio.com
2
Funding Rounds
$8.7m
Money raised
A non-profit organization with a focus on scientific and engineering research. It was founded in 1941 and is located in Birmingham, Alabama.
Industries:
Location:
Key people:
1
Funding Rounds
Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease
Industries:
Location:
Key people:
6
Funding Rounds
$37.4m
Money raised
Developer of vaccines to provide broad-spectrum protection against highly mutating respiratory viruses.
Industries:
Location:
Key people:
- Alexandre Levert *******@osivax.com
- Alexandre Le Vert *******@osivax.com
- Florence Nicolas ********@osivax.com
1
Funding Rounds
$14.2m
Money raised
Stemirna Therapeutics is an mRNA therapeutics and nanoparticle formulation company in China focused on treatments for cancer, infectious diseases and rare diseases.
Industries:
Location:
Key people:
1
Funding Rounds
$22.8m
Money raised
Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.
Industries:
Location:
Key people:
2
Funding Rounds
$950.0k
Money raised
An operator of a biotechnology company in Massachusetts that focuses on improving the manufacture of immuno-therapeutics and dendritic cell-based vaccines.
Industries:
Location:
Key people:
3
Funding Rounds
$61.4m
Money raised
ISA Pharmaceuticals is a synthetic therapeutic vaccines founded in 2004 by Cornelius Melief.
Industries:
Location:
Key people:
6
Funding Rounds
$714.0m
Money raised
Secfi is the pre-wealth advisor for startup employees. Figuring out what to do with your equity-based compensation is complicated and expensive and is therefore ignored and neglected. Secfi makes handling startup equity compensation simple and affordable. We build technology that helps employees make the right decisions for their equity compensation. By addressing their biggest concerns they can spend time on things they love doing most. We are hiring! Find out more at https://www.secfi.com/careers/
3
Funding Rounds
$348.5m
Money raised
Vaccine Discovery Technology Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Industries:
Location:
Key people:
7
Funding Rounds
$24.5m
Money raised
Immunophotonics is a company developing immunotherapy-based treatments for cancer founded in 2012 by Lu Alleruzzo.
Industries:
Location:
Key people:
- Lu Alleruzzo **@immunophotonics.com
- Tomas Hode *****@immunophotonics.com
3
Funding Rounds
$141.0m
Money raised
Bharat Biotech is an Indian vaccine manufacturer and pharmaceutical company.
2
Funding Rounds
$5.0m
Money raised
ANA Therapeutics is a Foster City, California-based developer of a novel corona vaccine.
Industries:
Location:
Key people:
- Akash Bakshi *****@yourchoicetx.com
- Nadja Mannowetz
- Andrew Bartynski ******@anatherapeutics.com
3
Funding Rounds
$2.8m
Money raised
EpiVax Oncology is a Providence, Rhode Island-based company founded by Gad Berdugo, Anne de Groot and Bill Martin.
Industries:
Location:
Key people:
- Gad Berdugo ********@epivaxtx.com
- Anne de Groot ******@epivax.com
- Bill Martin
2
Funding Rounds
$49.0m
Money raised
LabConnect provides comprehensive central lab services for clinical development programs including routine and complex laboratory testing for biopharmaceutical and CRO clients.
Industries:
Location:
1
Funding Rounds
$7.5m
Money raised
Flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in hosts
Industries:
Key people:
3
Funding Rounds
$65.1m
Money raised
MinervaX is a Copenhagen-based company founded in 2010 by Per Fischer.
1
Funding Rounds
$56.0m
Money raised
Biotechnology company focused on developing vaccines for herpes.
Industries:
Location:
Key people:
3
Funding Rounds
$26.8m
Money raised
Mazen Animal Health Inc. is a company founded in 2016.
Industries:
Location:
2
Funding Rounds
$63.4m
Money raised
Pfenex is a biotechnology company focused on protein therapies
5
Funding Rounds
$32.9m
Money raised
FluGen is a vaccines & Adjuvants founded in 2007 by Paul Radspinner, Gabriele Neumann and Yoshihiro Kawaoka.
Industries:
Location:
Key people:
- Paul Radspinner ***********@flugen.com
- Gabriele Neumann
- Yoshihiro Kawaoka
2
Funding Rounds
$15.5m
Money raised
OncoPep is a company developing immunotherapeutics for thetreatment of cancer founded in 2010 by Doris Peterkin, Ken Anderson and Marc Cohen.
Industries:
Location:
Key people:
3
Funding Rounds
$79.7m
Money raised
Synklino is an immunotoxin drug for cytomegalovirus in transplant recipients founded in 2017 by Thomas Kledal Ph.D., MBA , Mads Jeppesen Ph.D. and Mette Rosenkilde MD, Ph.D. .
Industries:
Location:
1
Funding Rounds
$2.0m
Money raised
Vivaldi Biosciences is a biotechnology company developing live attenuated influenza vaccines founded in 2010 by Adolfo García-Sastre, Peter Palese and Elliott Kieff.
Industries:
Location:
Key people:
2
Funding Rounds
$24.0m
Money raised
A company focused on research, development and manufacture of vaccines against various infectious diseases
Industries:
Location:
Key people:
1
Funding Rounds
$8.0m
Money raised
Treos Bio is a cancer Vaccine Technology founded in 2013 by John Hautman.
1
Funding Rounds
Enesi Pharma Limited is a solid Dose Vaccine Delivery founded in 2017.
Industries:
Location:
2
Funding Rounds
$12.6m
Money raised
Oxford Vacmedix UK Limited is a cancer Vaccines founded in 2012 by Dr Shisong Jiang.
2
Funding Rounds
$6.9m
Money raised
UbiVac is a vaccine / Immunotherapy founded in 2005 by Bernard A. Fox.
Industries:
Key people:
1
Funding Rounds
$55.0m
Money raised
ReViral is a biotechnology firm developing antiviral treatments for patients founded in 2011.
Location:
3
Funding Rounds
$22.3m
Money raised
Virus-like Particle Vaccines
Industries:
Location:
Key people:
1
Funding Rounds
$14.0m
Money raised
A company focused on the development of immunotherapeutics and preventative vaccines for fungal and bacterial disease
Industries:
Location:
Key people:
6
Funding Rounds
Vaccines
Industries:
Location:
Key people:
3
Funding Rounds
$60.0m
Money raised
A biotechnology company developing therapies and personalized diagnostics for celiac disease
Industries:
Key people:
2
Funding Rounds
$4.6m
Money raised
Scancell is a cancer vaccine founded in 1996 by Professor Lindy Durrant.
1
Funding Rounds
$4.4m
Money raised
Etubics is a targeted immunotherapies and vaccine products founded in 2005 by Frank R. Jones.
2
Funding Rounds
$11.8m
Money raised
Piroutte Medical is a Boston-based company developing drug-delivery medical devices.
Industries:
Key people:
- Elijah Kapas ***@pirouettemedical.com
- Matthew Kane *******@pirouettemedical.com
- Conor Cullinane **********@pirouettepharma.com
2
Funding Rounds
$70.0m
Money raised
A company developing vaccines for flu, malaria, dengue, papillomavirus and respiratory syncytial virus
Industries:
Location:
9
Funding Rounds
$102.9m
Money raised
ILIAD BIOTECHNOLOGIES, LLC is a pertussis Vaccine founded in 2012 by Keith Rubin, M.D..
1
Funding Rounds
$144.0m
Money raised
Panacea Biotec is a differentiated generics, vaccines, biosimilars founded in 1994 by Soshil Kumar Jain.
Industries:
Key people:
2
Funding Rounds
$8.0m
Money raised
A company developing preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer
2
Funding Rounds
$4.8m
Money raised
3P Biopharmaceuticals is a manufacturing & Services founded in 2006.
Industries:
1
Funding Rounds
$34.1m
Money raised
Affiris Ag is a therapeutic Vaccines founded in 2004 by Frank Mattner.
Industries:
Location:
Key people:
1
Funding Rounds
$60.0m
Money raised
Curevo Vaccine is a company founded in 2018.
Industries:
Location:
4
Funding Rounds
$5.8m
Money raised
PathoVax is an HPV vaccine founded in 2014 by Joshua Wang.
1
Funding Rounds
Sequoia Sciences is a company founded in 2012 by Gary Eldridge.
Industries:
Key people:
3
Funding Rounds
$100.0k
Money raised
Immunotherapies for Bacterial Infections
Industries:
Location:
1
Funding Rounds
Abcombi Biosciences is a company founded in 2015 by Andrew Hill, Ph.D. .
Industries:
Location:
Key people:
2
Funding Rounds
Viral vector engineering, transduction enhancement and technology development
Industries:
Location:
1
Funding Rounds
$2.5m
Money raised
Xeptiva Therapeutics is an innovative biotech that develops novel therapies for the veterinary market
1
Funding Rounds
Integrated BioTherapeutics is a vaccines, Biologics, Monoclonals founded in 2009 by M. Javad Aman.
Industries:
Location:
Key people:
1
Funding Rounds
$3.0m
Money raised
Scandinavian Biopharma Holding is a various vaccines founded in 2010 by Björn Sjöstrand.
1
Funding Rounds
Cytuvax is a vaccine Adjuvant founded by René Vleugels, PhD.